Special items: Ovarian Cancer and Us blog best viewed in Firefox

Wednesday, April 27, 2011

NICE Unable To Recommend Ovarian Cancer Drug In Final Guidance Due To Lack Of Appropriate Evidence (trabectedin (Yondelis)


No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.